The Trivacan study.
Nüesch
Reto
R
D000963:Antimetabolites / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D006801:Humans; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use*
D000963:Antimetabolites; D015215:Zidovudine